trending Market Intelligence /marketintelligence/en/news-insights/trending/voieuag98ln6gdcmk2cmmw2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Pluristem, Innovative Medical to extend investment agreement

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry

Cable Nets Struggle With Little Revenue Growth Expanding Programming Budgets


Pluristem, Innovative Medical to extend investment agreement

Pluristem Therapeutics Inc. and Innovative Medical Management Co. Ltd. mutually agreed to extend the execution time of the definitive agreements for Innovative Medical's proposed investment of $30 million.

The decision comes after the recently adopted Chinese policy relating to outbound investments by Chinese companies.

Both companies planned to enter into definitive agreements no later than Dec. 26 and plan to continue the discussions for the agreements until they have received further clarification about such policies, which is expected during the first half of 2017.

Innovative Medical is a publicly listed Chinese company active in the healthcare industry.